BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34257607)

  • 1. High Expression of Tomm34 and Its Correlations With Clinicopathology in Oral Squamous Cell Carcinoma.
    Cai M; Tan R; Huang Y; Chen X; Kong Q; Guo K; Xu M
    Pathol Oncol Res; 2021; 27():641042. PubMed ID: 34257607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOMM34 promotes cell proliferation, migration, and invasion of OSCC and modulates mitochondrial function.
    Huang Y; Chen Z; Chen X; Chen X; Xu M
    J Oral Pathol Med; 2023 Jan; 52(1):47-55. PubMed ID: 36367442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter DNA Methylation and mRNA Expression Level of p16 Gene in Oral Squamous Cell Carcinoma: Correlation with Clinicopathological Characteristics.
    Allameh A; Moazeni-Roodi A; Harirchi I; Ravanshad M; Motiee-Langroudi M; Garajei A; Hamidavi A; Mesbah-Namin SA
    Pathol Oncol Res; 2019 Oct; 25(4):1535-1543. PubMed ID: 30511108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
    Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
    Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
    Wei H; Yu K; Liu Y; Li L; Wang G
    BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
    Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
    Kouketsu A; Sato I; Abe S; Oikawa M; Shimizu Y; Takahashi T; Kumamoto H
    J Oral Pathol Med; 2016 Sep; 45(8):565-72. PubMed ID: 26711722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
    Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 Expression at Metastatic Lymph Nodes Predicts Unfavorable Outcome in Patients with Oral Squamous Cell Carcinoma.
    Kato K; Miyazawa H; Kobayashi H; Noguchi N; Lambert D; Kawashiri S
    Pathol Oncol Res; 2020 Oct; 26(4):2105-2113. PubMed ID: 31907776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.
    Piao S; Liu Y; Hu J; Guo F; Ma J; Sun Y; Zhang B
    PLoS One; 2012; 7(8):e42540. PubMed ID: 22880026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of HMGA2, P16, and HPV in oral squamous cell carcinomas.
    Loeschke S; Ohlmann AK; Bräsen JH; Holst R; Warnke PH
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1422-9. PubMed ID: 27421171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma.
    Erber R; Spoerl S; Mamilos A; Krupar R; Hartmann A; Ruebner M; Taxis J; Wittenberg M; Reichert TE; Spanier G; Spoerl S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma.
    Hsu CW; Chang KP; Huang Y; Liu HP; Hsueh PC; Gu PW; Yen WC; Wu CC
    Mol Cell Proteomics; 2019 Oct; 18(10):1939-1949. PubMed ID: 31315917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Rao RS; Raju K L; Augustine D; Patil S
    Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
    Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
    BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.